The effect of diabetes medications on the risk of developing cancer

FHS
July 25, 2023
10:08 am

In an attempt to discern the risk of cancer posed by certain diabetic drugs as well, the authors of a recent paper performed a systematic review and meta-analysis of all studies over the past ten years dealing with this topic.

Hikma to take over several assets from Xellia, including a US manufacturing site

Generic drug company Hikma is bolstering its portfolio by acquiring parts of Xellia Pharmaceuticals’ finished dosage form business in the US. This includes Hikma taking

June 19, 2024

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for Ovarian Cancer: Likelihood of Approval

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technology and currently in Phase II for Ovarian Cancer.

April 19, 2024

J&J touts success of Vyvgart competitor in two autoimmune disease trials, including key myasthenia gravis study

Johnson & Johnson’s experimental antibody nipocalimab reduced the severity of symptoms related to two autoimmune conditions — first in a pivotal study for generalized myasthenia

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.